In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Danaher shells out $1.1bn for MDS division and Sciex JV

Executive Summary

Danaher is buying MDS Analytical Technologies (including its Molecular Devices division) and MDS's 50/50 mass spectrometry joint venture with Life Technologies for a total of $1.1bn in cash--MDS gets $650mm (about 65% will support a share buyback program) and LT receives $450mm ($290mm will be used to repay debt).
Deal Industry
  • Medical Devices
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Drug Discovery Tools
Deal Status
  • Final
Deal Type
  • Acquisition
    • Acquisition of Private Biotech
    • Full Acquisition
    • Payment Includes Cash

Related Companies